Ithaka Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.5M Buy
20,152
+11,577
+135% +$11.7M 3.85% 9
2025
Q4
$9.22M Buy
8,575
+168
+2% +$161K 1.64% 23
2025
Q3
$6.41M Buy
8,407
+4
+0% +$2.98K 1.1% 29
2025
Q2
$6.55M Sell
8,403
-156
-2% -$121K 1.12% 31
2025
Q1
$7.07M Buy
8,559
+8,059
+1,612% +$6.71M 1.44% 26
2024
Q4
$386K Hold
500
0.07% 33
2024
Q3
$443K Hold
500
0.08% 34
2024
Q2
$453K Hold
500
0.08% 35
2024
Q1
$389K Hold
500
0.07% 34
2023
Q4
$291K Hold
500
0.06% 35
2023
Q3
$269K Hold
500
0.06% 32
2023
Q2
$234K Buy
+500
New +$210K 0.05% 34

Other funds holding LLY

Ithaka Group's LLY Position: Q1 2026 in Review

Ithaka Group increased its Eli Lilly (LLY) stake by 135% in Q1 2026, buying an estimated $11.7M and bringing the position to 20,152 shares worth $18.5M. The position accounts for 3.85% of the portfolio, ranked #9.

Ithaka Group first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ithaka Group held 20,152 shares of Eli Lilly worth $18.5M as of Q1 2026.
  • Ithaka Group bought 11,577 Eli Lilly shares in Q1 2026, an estimated $11.7M.
  • Eli Lilly made up 3.85% of Ithaka Group's portfolio in Q1 2026, its #9 holding.
  • Ithaka Group first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ithaka Group's 13F filing for Q1 2026, filed 12 May 2026.